A US drug company has increased the price of an acne cream by more than 3,900% to $9,561 in less than 18 months in the latest example of drug “price gouging”, which has enraged the American public and become a central topic of debate in the presidential election campaign.The spokesweasel for Novum said that their products are "affordable to patients", which is a huge laugh in and of itself.
Novum Pharma, a recently formed privately held Chicago-based company, bought the rights to drug Aloquin in May 2015. The 60g cream, which contains two cheap ingredients, was sold by its previous owner, Primus Pharmaceuticals, for $241.50.
Novum almost immediately increased the price by 1,100%, and hiked the price higher still in January 2016. Figures seen by the Financial Times show the company increased the price a third time last week to take the cost to $9,561.
I don't know who the dead-armadillo-blowing bottom-feeders are who own the company, but I expect that information will soon be ferreted out and they will reap the public scorn and ridicule that they so richly deserve.